Key points are not available for this paper at this time.
This article presents the results of a study of individual theoretical, methodological and empirical aspects of the relationship between innovative macrofinancial policy and long-term economic growth. The research revealed that the scale of innovation largely depends on government subsidies and investment preferences. Improving the quality of innovation requires innovation in the relevant field and contributions to subsequent technological innovations. The quality of innovation depends more on another level of factors and the flow of information. Firms prefer to engage in high-quality innovation activities for the sake of market competition, and the factor of institutional conjuncture has less impact on the quality of innovation. Thus, the article explores the hypothesis that, all other things being equal, deviation from the GDP target weakens the innovative effect of government subsidies. The study was conducted based on the empirical experience of countries with fast-growing economies, in particular, such as China, India, etc. The results also show that asymmetric effects affect the number of innovations rather than their quality. The heterogeneity shows that R&D subsidies are more dependent on the deviation of the GDP target and reduce the effectiveness of corporate innovation compared to non-R&D subsidies. In addition, the asymmetric innovation effect of government subsidies is more noticeable in companies that are subject to less institutional control. Empirical results obtained as a result of econometric calculations and estimates allow us to take a fresh look at the innovative effect of government subsidies through the prism of deviations from the GDP target
Bahadyr J. Matrizaev (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: